{"title":"Making breast cancer innovation deliver for every woman","authors":"Miriam Mutebi","doi":"10.1038/s41568-026-00982-4","DOIUrl":"https://doi.org/10.1038/s41568-026-00982-4","url":null,"abstract":"","PeriodicalId":19055,"journal":{"name":"Nature Reviews Cancer","volume":"3 1","pages":""},"PeriodicalIF":78.5,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148922934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Giulio Caravagna, Trevor A Graham, Andrea Sottoriva
{"title":"A guide to understanding tumour evolution through the lens of population genetics.","authors":"Giulio Caravagna, Trevor A Graham, Andrea Sottoriva","doi":"10.1038/s41568-026-00973-5","DOIUrl":"https://doi.org/10.1038/s41568-026-00973-5","url":null,"abstract":"<p><p>Every cancer carries the history of its own evolution, hidden in its genome. Modern DNA sequencing can catalogue millions of mutations and profile tumours across space and time, but sequencing alone struggles to answer the questions that matter most: when did key adaptations emerge, how strongly were they selected, why do some tumours relapse whereas others do not, and how will the cancer evolve next? The reason is fundamental: sequencing is a snapshot, whereas evolution is a dynamic process. Bridging this gap requires moving beyond descriptive cancer genomics towards quantitative evolutionary inference. In this Review, we argue that population genetics provides the mathematical framework needed to extract evolutionary dynamics from cancer genomes. We show how models of mutation, selection and drift transform allele frequencies from descriptive measurements into quantitative estimates of clonal fitness and evolutionary timings. We discuss how these principles extend to epigenetic inheritance, plasticity and ecological interactions within the tumour ecosystem, and examine the assumptions and limitations for their application to modern sequencing data. By reframing cancer genomes as quantitative records of evolutionary processes rather than catalogues of mutations, researchers have used population genetics to provide a foundation for understanding - and ultimately predicting - the trajectories of cancer evolution.</p>","PeriodicalId":19055,"journal":{"name":"Nature Reviews Cancer","volume":" ","pages":""},"PeriodicalIF":60.7,"publicationDate":"2026-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148920764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Allan Balmain, René Bernards, Hans Clevers, Karen H. Vousden, Paul Workman, Marinka Zitnik
{"title":"Reflecting on 25 years of cancer research: transformative advances and unmet expectations","authors":"Allan Balmain, René Bernards, Hans Clevers, Karen H. Vousden, Paul Workman, Marinka Zitnik","doi":"10.1038/s41568-026-00974-4","DOIUrl":"10.1038/s41568-026-00974-4","url":null,"abstract":"For the 25th anniversary of Nature Reviews Cancer, we invited six researchers to reflect on the past 25 years of cancer research, highlighting the most transformative conceptual advances, as well as those that did not fulfil their initial promise or were fundamentally misunderstood. To mark the 25th anniversary of Nature Reviews Cancer, six researchers reflect on the conceptual advances that have reshaped cancer research — from somatic mosaicism, functional genomics and cancer stem cells to tumour metabolism, precision oncology and artificial intelligence — and consider which ideas transformed the field, which fell short of expectations, and what challenges remain.","PeriodicalId":19055,"journal":{"name":"Nature Reviews Cancer","volume":"26 10","pages":"750-755"},"PeriodicalIF":60.7,"publicationDate":"2026-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148912916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Franco Izzo, Tamara Prieto, Catherine Potenski, Dan A Landau
{"title":"A single-cell lens into the co-evolution of genotypes and phenotypes in cancer.","authors":"Franco Izzo, Tamara Prieto, Catherine Potenski, Dan A Landau","doi":"10.1038/s41568-026-00970-8","DOIUrl":"https://doi.org/10.1038/s41568-026-00970-8","url":null,"abstract":"<p><p>Genetic heterogeneity and clonal outgrowths are observed even in otherwise healthy human tissues, shaping the genetic composition of cell populations in non-malignant disease and during physiological ageing. This clonal mosaicism likely provides the pre-cancerous seeds for malignant transformation. Once a tumour arises, clonal evolution poses a major challenge to achieving cure, as clonal diversification provides an expanded number of substrates upon which therapy can act as a selective pressure, leading to the selection of resistant clones that ultimately fuel disease recurrence. Understanding somatic clonal evolution requires not only mapping genetic diversity but also defining the resulting phenotypes that provide a fitness advantage to mutated clones. This Review discusses multimodal single-cell technologies that enable the measurement of genotypes and additional molecular features from the same cell. These technologies unveil mutant-specific phenotypic traits, often show cell-state specificity in genotype-phenotype effects and can define therapeutic vulnerabilities for precision elimination of disease-propagating mutant cells. Furthermore, the combination of phylogenetic reconstruction with phenotypic measurements allows for the temporal mapping of clonal evolution and phenotypic plasticity. These breakthroughs have created a unique opportunity to define, directly in primary human samples, the mechanisms underlying clonal expansion in both healthy and malignant tissues.</p>","PeriodicalId":19055,"journal":{"name":"Nature Reviews Cancer","volume":" ","pages":""},"PeriodicalIF":60.7,"publicationDate":"2026-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148912989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Markus I Diehl, Pamela A Basto, Matthew A Abikenari, Ian L Linde, Derick Okwan-Duodu, Edgar G Engleman
{"title":"Neutrophils in cancer.","authors":"Markus I Diehl, Pamela A Basto, Matthew A Abikenari, Ian L Linde, Derick Okwan-Duodu, Edgar G Engleman","doi":"10.1038/s41568-026-00968-2","DOIUrl":"https://doi.org/10.1038/s41568-026-00968-2","url":null,"abstract":"<p><p>Neutrophils, long appreciated for their central role in host defences, have largely pro-tumorigenic effects in cancer owing to their sensitivity to signals in the tumour environment. Cancers regularly co-opt the functions of neutrophils to promote angiogenesis, immunosuppression, tumour growth and metastasis. However, depending on context, many of the same neutrophil-derived factors involved in these processes can mediate tumour cell killing. In this Review, we examine the functions of neutrophils and their impact on cancer, drawing parallels between their roles in cancer and non-cancer contexts, and highlighting their remarkable sensitivity to environmental cues. We call attention to promising strategies for targeting and manipulating neutrophils for the treatment of cancer.</p>","PeriodicalId":19055,"journal":{"name":"Nature Reviews Cancer","volume":" ","pages":""},"PeriodicalIF":60.7,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148906676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Myriam Chalabi, Tim H. H. Coorens, Leanne Li, James L. Reading, Shensi Shen, Ewa Szczurek
{"title":"The next 25 years of cancer research: emerging perspectives and priorities","authors":"Myriam Chalabi, Tim H. H. Coorens, Leanne Li, James L. Reading, Shensi Shen, Ewa Szczurek","doi":"10.1038/s41568-026-00975-3","DOIUrl":"10.1038/s41568-026-00975-3","url":null,"abstract":"Over the past 25 years, cancer research has undergone profound conceptual and technological advances, yet major challenges remain. As Nature Reviews Cancer marks its 25th anniversary, we turn our attention to the future of the field. Believing that emerging investigators are uniquely positioned to challenge prevailing assumptions, adopt new interdisciplinary approaches and redefine research priorities, we asked them to share how they envision the future of cancer research. Here they highlight conceptual opportunities, identify paradigms in need of re-evaluation and discuss the approaches they believe will most strongly shape the field over the next 25 years. To mark the 25th anniversary of Nature Reviews Cancer, six emerging cancer researchers share their perspectives on the future of the field, highlighting conceptual opportunities, challenging established paradigms and identifying the approaches they believe will drive progress in the field over the next 25 years.","PeriodicalId":19055,"journal":{"name":"Nature Reviews Cancer","volume":"26 10","pages":"756-761"},"PeriodicalIF":60.7,"publicationDate":"2026-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148906698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Expanding the reach of menin inhibitors","authors":"Daniela Senft","doi":"10.1038/s41568-026-00981-5","DOIUrl":"10.1038/s41568-026-00981-5","url":null,"abstract":"Megakaryocytes contribute substantially to the pathogenesis of myeloproliferative neoplasms (MPNs), but therapeutic strategies targeting this lineage are lacking. Wen, Cotton et al. demonstrate that menin inhibition impairs megakaryocyte differentiation, suppresses myelofibrosis and improves disease features across preclinical MPN models.","PeriodicalId":19055,"journal":{"name":"Nature Reviews Cancer","volume":"26 10","pages":"749-749"},"PeriodicalIF":60.7,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148881254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The long return on discovery science in cancer therapeutics","authors":"Cian Murphy, Samuel Hume, Charles Swanton","doi":"10.1038/s41568-026-00978-0","DOIUrl":"10.1038/s41568-026-00978-0","url":null,"abstract":"Many advances in cancer treatment depend on discoveries made decades earlier. In this Comment, Murphy et al. discuss the histories of EGFR, HER2, CDK4/6 and RAS, highlighting how long translation can take and how clinical benefit can continue to accumulate as more effective drugs are developed, used in earlier disease settings and combined with existing treatments.","PeriodicalId":19055,"journal":{"name":"Nature Reviews Cancer","volume":"26 10","pages":"745-747"},"PeriodicalIF":60.7,"publicationDate":"2026-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148851127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ruiyi Tian, Sina Azadnajafabad, Erika A. Waters, Emily P. Balskus, Yasmine Belkaid, Jordana T. Bell, Sarah E. Berry, Jason D. Buenrostro, Curtis Huttenhower, Anisha Patel, Gary J. Patti, Nicola Segata, Bhawna Sirohi, Tim D. Spector, Ömer H. Yilmaz, Andrew T. Chan, Yin Cao
{"title":"Shaping the future of early-onset colorectal cancer prevention","authors":"Ruiyi Tian, Sina Azadnajafabad, Erika A. Waters, Emily P. Balskus, Yasmine Belkaid, Jordana T. Bell, Sarah E. Berry, Jason D. Buenrostro, Curtis Huttenhower, Anisha Patel, Gary J. Patti, Nicola Segata, Bhawna Sirohi, Tim D. Spector, Ömer H. Yilmaz, Andrew T. Chan, Yin Cao","doi":"10.1038/s41568-026-00965-5","DOIUrl":"10.1038/s41568-026-00965-5","url":null,"abstract":"Early-onset colorectal cancer (EOCRC) among individuals under age 50 is increasing globally. Lifestyle factors such as obesity, metabolic comorbid conditions, poor diet and sedentary behaviours are linked to EOCRC, but critical gaps remain in identifying additional risk factors, with growing evidence for early-life and gut microbial-related exposures. In addition, how or when the risk factors act, individually or collectively, to initiate or promote colorectal cancer at much younger ages remains unknown. Compounding the complexity are the unique challenges of developing and implementing effective prevention strategies among younger populations. In this Roadmap, we review the progress and challenges of risk factor discovery for EOCRC, highlight opportunities for prevention and propose a transdisciplinary framework integrating population, mechanistic, behavioural and implementation sciences to accelerate causal risk factor discovery and translate insights into strategies to reverse the rising EOCRC burden. This framework, exemplified by emerging global initiatives including the Cancer Grand Challenges team PROSPECT, is broadly adaptable and intended to inspire collaborative efforts across the field. We also emphasize the critical role of patient perspectives and public engagement in shaping these efforts. With the urgency in risk factor discovery, scientists, the public and policymakers must unite to transform knowledge into life-saving solutions for future generations. Early-onset colorectal cancer is rising globally. This Roadmap examines current knowledge gaps in risk factors, proposes an integrative conceptual model for risk factor discovery and prevention, and highlights the role of transdisciplinary science and patient engagement in reversing the trend.","PeriodicalId":19055,"journal":{"name":"Nature Reviews Cancer","volume":"26 10","pages":"830-848"},"PeriodicalIF":60.7,"publicationDate":"2026-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148830891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Early evidence of the carcinogenic effects of e-cigarette use.","authors":"Yolanda I Chirino, Estefany I Medina-Reyes","doi":"10.1038/s41568-026-00976-2","DOIUrl":"https://doi.org/10.1038/s41568-026-00976-2","url":null,"abstract":"","PeriodicalId":19055,"journal":{"name":"Nature Reviews Cancer","volume":" ","pages":""},"PeriodicalIF":60.7,"publicationDate":"2026-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148830901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}